MannKind Corporation (MNKD): Short Seller Sentiment is Bearish on This Stock

MannKind Corporation (NASDAQ:MNKD) is a U.S.-based biopharmaceutical company focused on developing and commercializing inhaled therapies for endocrine and orphan lung diseases. We have been looking at biotech stocks with high short interest and MNKD attracted our attention. MannKind Corporation (NASDAQ:MNKD) Short % of Float: 14.60% Number of Hedge Fund Holders: 20 In Q2 2024, MannKind […]